Recent Finacing
Recent Raise
SpyGlass Pharma is an ophthalmic biotech developing an intraocular lens‑mounted, sustained‑release platform to deliver multi‑year bimatoprost therapy to targeted ocular tissues, in Phase I/II with planned Phase III trials.
